CVE-2023-23918

Description

A privilege escalation vulnerability exists in Node.js <19.6.1, <18.14.1, <16.19.1 and <14.21.3 that made it possible to bypass the experimental Permissions (https://nodejs.org/api/permissions.html) feature in Node.js and access non authorized modules by using process.mainModule.require(). This only affects users who had enabled the experimental permissions option with --experimental-policy.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.02%
Vendor Advisory nodejs.org
Affected: NodeJS Node
Published at:
Updated at:

References

Link Tags
https://nodejs.org/en/blog/vulnerability/february-2023-security-releases/ patch vendor advisory
https://security.netapp.com/advisory/ntap-20230316-0008/

Frequently Asked Questions

What is the severity of CVE-2023-23918?
CVE-2023-23918 has been scored as a high severity vulnerability.
How to fix CVE-2023-23918?
To fix CVE-2023-23918, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-23918 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-23918 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-23918?
CVE-2023-23918 affects NodeJS Node.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.